We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLV icon
576
PUT
iShares Silver Trust
SLV
$31.3B
$33K 0.01%
+800
New +$28.7K
TIC
577
TIC Solutions Inc
TIC
$2.19B
$33K 0.01%
+2,500
New +$28.5K
ATEX icon
578
Anterix
ATEX
$1.79B
$32K 0.01%
1,500
-400
-21% -$8.97K
CEVA icon
579
CEVA Inc
CEVA
$855M
$32K 0.01%
1,229
-710
-37% -$16.5K
IIPR icon
580
Innovative Industrial Properties
IIPR
$1.67B
$32K 0.01%
+600
New +$32.6K
IMVT icon
581
Immunovant
IMVT
$8.64B
$32K 0.01%
2,000
– –
KBR icon
582
KBR
KBR
$4.81B
$32K 0.01%
+682
New +$33.1K
UPBD icon
583
Upbound Group
UPBD
$1.15B
$32K 0.01%
+1,365
New +$33.7K
CC icon
584
Chemours
CC
$2.3B
$31K 0.01%
2,000
-2,000
-50% -$29K
CDNA icon
585
CareDx
CDNA
$2.45B
$31K 0.01%
+2,133
New +$30.4K
OMEX icon
586
Odyssey Marine Exploration
OMEX
$53.4M
$31K 0.01%
+16,380
New +$26.4K
GUTS icon
587
Fractyl Health
GUTS
$105M
$31K 0.01%
+20,000
New +$25.9K
SOLV icon
588
Solventum
SOLV
$14.7B
$31K 0.01%
430
-10
-2% -$733
ABTS icon
589
Abits Group
ABTS
$3.94M
$30K 0.01%
+3,366
New +$16.2K
CADE
590
DELISTED
Cadence Bank
CADE
$30K 0.01%
800
– –
CNDT icon
591
Conduent
CNDT
$252M
$30K 0.01%
10,920
+5,165
+90% +$14K
CXM icon
592
Sprinklr
CXM
$1.65B
$30K 0.01%
4,000
– –
ESAB icon
593
ESAB
ESAB
$5.29B
$30K 0.01%
+274
New +$32.6K
NSC icon
594
Norfolk Southern
NSC
$75.9B
$30K 0.01%
100
+87
+669% +$24.2K
STWD icon
595
Starwood Property Trust
STWD
$6.05B
$30K 0.01%
+1,600
New +$32.2K
ALM
596
Almonty Industries
ALM
$4B
$30K 0.01%
+5,000
New +$22.7K
BETR icon
597
Better Home & Finance Holding
BETR
$21.6M
$29K 0.01%
+525
New +$11.7K
BOIL icon
598
ProShares Ultra Bloomberg Natural Gas
BOIL
$402M
$29K 0.01%
500
+250
+100% +$17K
LUNG icon
599
Pulmonx
LUNG
$92.8M
$29K 0.01%
+18,366
New +$38.4K
UL icon
600
Unilever
UL
$135B
$29K 0.01%
+444
New +$30.6K
22 23
24
25 26

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.